Control Bionics Limited [ASX:CBL] share price and news 2022

Company Description

Control Bionics Limited (CBL) designs, manufactures and sells wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. This allows users to operate and communicate via a computer using intentional thought and the body’s own neuroelectric signals detected at skeletal muscle sites – the physical movement of a muscle is not necessary for the technology to detect and interface.

Control Bionics Limited belongs to Health Care sector and under industry of Health Care Equipment. You can get more information about this company via their website: http://www.controlbionics.com.

This a small cap company with market cap of 33 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 2.73 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how cbl dividend grows in the recent years.Control Bionics Limited has dividend yield of 0.48%